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Abstract: This research develops an interactive module system that 
can be used to explore and build a self-assessment checklist on 
significant learning content in the daily life and work of students in the 
future.  The role and status of Patent laws in the protection of plant 
species which have been genetically modified is currently uncertain in 
India. Discussions and debates regarding the same are rife and experts 
have different views regarding the whole aspect concerning 
economical and ethical considerations. Genetically engineered plants 
and modified crop plants are of significant economic value. In India, 
they face critical challenges, for instance, the requirement of 
dependable public policies and vigorous frameworks for regulatory 
control. This becomes much more vital since India desires to be an 
economic superpower primarily based on innovation. It is very 
important for a person from the legal field, especially those interested 
in the field of IPR, to have clarity regarding the protection of 
genetically modified plants. This humble attempt at a research paper 
seeks to clarify the same and discusses the various aspects on which 
one should think while concluding their views on the topic. 
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1. Introduction 
Although there are shreds of evidence of displacement of varieties of plants and biodiversity with the 
help of natural routes since ancient times, it was during the middle of the 1960s that Dr Norman 
Borlaug of Mexico created the foremost high-yielding variety of wheat seeds. Subsequently, the 
technology was followed all over the world. In 1966, the development of the high-yielding variations 
of wheat under the “High-Yielding Varieties Program (HYVP)”, was introduced and further 
facilitated in India [1]. India has always been a country where the majority of people earn their 
livelihood through agriculture. Post the British era, 80% of the population were dependent upon 
agriculture for their daily bread and butter. Even today, about 55% of the population earn their 
livelihood, either directly or indirectly, through farming. Implementation of the HYVP helped in 
overcoming the food catastrophe faced by Indians in the 1960s which was life-threatening. Due to the 
HYVP, there was a rise in agricultural productivity which in turn led to the Green Revolution picking 
up momentum in the country. This factor played a very major role in ensuring self-sustainability in 
the Indian economy. 
As the country entered the new epoch, an increased cost of living along with an expanded 
population accompanied by a lack of access to resources, there arose a necessity and call to restructure 
the agriculture of the country by adopting the “Gene Revolution”. Two technologies evolved for 
shaping up the subsequent insurgency in plant-related and agricultural technologies in India. The first 
innovation is related to the “recombinant DNA technology (rDNA) that was established by Herbert 
Boyer and Stanley Cohen, eminent personalities in the field of biotechnology who started by 
developing the fundamental phenomenon of transporting genetic substance from one organism and 
artificially inducing it into the genome of another organism, where the genetic material so transported 
gets stimulated and expressed by the other organism [2].  
The “Genetically Modified Species” based on this technology, vary from old-style approaches in 
nature and previous traditional programs on plant breeding as they do not include general mingling of 
the genes between various plant types. Rather, these genetically modified organisms comprise of a 
very choosy and accurate transport of DNA from one creature carrying anticipated stretches of genetic 
matter that can transfer chosen behaviours to the recipient organism by engaging tissue culture 
methods. The above-mentioned technology has been familiar in the domain of agriculture and plant-
related biotechnology, as providing valuable tools. Products utilizing identical apparatuses have been 
expansively used to produce “Genetically Modified Organisms” and “Genetically Modified Plants”. 
The second technique, which has also been path-breaking, is the “Clustered Regularly Interspaced 
Short Palindromic Repeats (CRISPR) technology, which is a feature of the bacterial defence system 
that has been adapted and modified to make them the foundation for CRISPR-Cas9 genome 
expurgation technology accompanied with other alternate systems [3]. It can alter the agricultural and 
biotechnological fields, both economically as well as technologically. Utilizing such practises has the 
potential to change the technological and economical division of the country’s agriculture.  
Similar to the “Green Revolution”, which was a revolutionary acceptance of ground-breaking 
technical know-how that facilitated India to produce more than enough food for its population, the 
implementation of various technologies as mentioned above and “Genetically Modified Plants” had a 
big influence on the agricultural sector of the country. The necessity of dependable laws, policies, and 
healthy frameworks for supervising control pose noteworthy tests for genetically manufactured crops 
in India. The IP framework is strict in its ambit, and the existing judgments prevent fortification of the 
technical methods for the growth of “Genetically Modified Plants” under the prevailing provisions of 
Patents law in the country. This would possibly aid in disincentivizing players who have advanced 
proprietary methods by conveying their modern creations for utilization by farmers in India. 
There has been an attempt to study the integration of biotechnology and IPR, assuming that the 
legal background of the same is enveloped by several complications, hence a straight-jacket formula 
cannot be put into place to study it. Through intensive study of various sources, the researchers have 
tried to bring forth the science and technicality behind the genetic modification of plants and various 
aspects of international law that govern the arena, since the genetic modification of plants is a global 
phenomenon. Also, through a case study, the very modern and possibly appropriate approach of the 
Indian courts towards the same has been studied. Conclusively, the researchers want to emphasize the 
importance of IP laws – both national (India) and international – in plant genetic engineering and 
provide one of many possible perspectives to study the same. 
The purpose of this research paper is to analyse the current scenario concerning safeguards granted 
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to genetically engineered plants in India under the domain of IP Laws. The momentous amount of 
economic value attached to the genetically modified plant species cannot be denied. It is for this 
reason that the study carried out through this paper becomes very much important. The paper also 
includes within its ambit, the distinction between different procedures dealing with plant genetic 
engineering, whether the processes qualify as ‘essential biological processes,’ and what is their status 
under the Patents Act, 1970. 
 
2. Methodology 
Researchers have selected the topic to address the significant and impelling need of clarifying the 
subject matter in question. The method opted for this research paper is a doctrinal one which includes 
analysing the IP protection available to genetically modified plants in India through the relevant 
provisions of law and a very important case study. The questions or doubts have been clarified using a 
qualitative approach. Both legal as well as non-legal authorities such as International legal 
instruments, appropriate provisions of law, case analysis, books of both national as well as 
international repute, international law journals, trusted online sources, international journals on plant 
genetic engineering, reports and opinions of experts & research scholars have been dealt with in its 
entirety to collect the material information required for this research paper. 
 
3. Result and Discussion 
3.1. Plant Genetic Engineering and The Trips Agreement 
The World Trade Organisation is under an obligation under “TRIPS” to give protection under patent 
law to its members [4]. The protection provided shall be for two things i.e. the product as well as the 
process. All fields of technology shall be included under it, provided that the inventions are new, 
capable of having an industrial application, and involve innovation. The protection shall only be 
provided to microorganisms and plants & animals shall be omitted from it. Biological procedures for 
the creation of plants & animals shall not qualify to get any protection under patents but protection 
shall be extended to non-biological or microbiological processes. However, plant varieties are to be 
given mandatory protection. The “TRIPS Agreement, under Article 27(3) (b) deals with protection to 
plant varieties [4]. This particular provision states the items which are to be excluded from being 
protected under the patent law. However, the exception laid down under this provision states that 
adherents of the WTO shall only shield the plant varieties either under patents or under a “sui 
generis” scheme or a blend of both of them. Protection shall not be extended to plants, animals & 
other micro-organisms and also the biological procedures for preparing such plants, animals, and 
micro-organisms. 
Therefore, on reading the above provision, it can be concluded that though no protection has been 
provided to plants, a guard has been extended to plant variations. Followers of the WTO are also 
under an obligation to protect plant varieties under their municipal laws either under patents or under 
a “sui generis” scheme or a mixture thereof. The requirements for patent protection have been 
provided under the TRIPS agreement which includes newness, non-obviousness, and its applicability 
in the industry/usefulness. However, neither a detailed explanation to it has been provided under the 
agreement nor does it describe in detail the room of protection of patents on genetic matters and 
biotechnological procedures. Only minimum standards have been set out under. Therefore, the 
members shall not be obligated to grant protection which is more extensive in nature than provided 
under the TRIPS agreement. The protection provided by certain member states does not stand as an 
obligatory factor for other member states to provide that same amount of protection if the TRIPS 
agreement does not provide a mandate for doing so. It is also not required for a member state to 
provide identical safety to the nationals of all other member states as provided to its nationals. 
As stated above, in a case where the member states do not provide any guard to plant varieties 
under patents, protection is to be provided under the “sui generis” scheme or through a blend of both. 
Though the term “sui generis” has not been defined under the agreement, it means “setting up a 
system of its kind, i.e. creating a separate national law or establishment of international norms that 
would afford protection to IP which would be dealing with genetic resources or biodiversity [5] 
 
3.2. Patent Protection In India For Genetically Modified Plants 
On studying the technology involved, it may quite firmly be established that a transgenic plant is a 
GMO since there is a case of artificial transfer. India ratified TRIPS, following which the Ayyangar 
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Committee’s recommendations in its report were enacted in India in the form of the Patents Act. This 
report had also unambiguously elucidated on the issue of certain prohibitions under “Section 3(h) of 
the Patents Act. These prohibitions excluded methods of agriculture or horticulture from patentability 
[6]. The intent for it was to apply to creations in the arena of plant proliferation by nonsexual means. 
The current stance of the Indian Patent Office has been seen as to acknowledge and account every 
usual practice done in an open field as a system of agriculture. As a consequence, any claim in a 
patent application that is marked as containing terms such as ‘germinate,’ ‘seeds,’ ‘hybrid,’ ‘variety,’ 
etc. is deemed to be excluded from patentability. 
 
 In 2002, Section 3(i) of the Patents Act was amended. Before the amendment the Section read 
as follows:  
 
“any process for the medicinal, surgical, curative, prophylactic or other treatment of 
human beings or any process for similar treatment of animals or plants to render them 
free of disease or to increase their economic value or that of their products [6]. 
 
Post amendment, the phrase “or plants” was struck out. Thus, the handling of plants to purify it or 
to grow its monetary value does not come under any of the segregations as under Section 3. Further, 
“Section 3(c) of the Act excludes the discovery of ‘naturally occurring living things’ or ‘non-living 
substances’ from patentable subject matters [6]. ‘Discovery’ does not, however, include DNA that has 
been modified, a recombinant DNA construct, or any modified protein molecule as they require 
substantial human intervention and lab work. These aren’t thus patentable for the stated reason. 
Furthermore, “Section 3(j) of the Act excludes parts or whole of plants and animals, seeds, varieties 
and species and essentially biological processes for creation or dissemination of plants and animals, 
from the patentable subject matter [6]. Microorganisms are not excluded. 
The conventional methods utilised by India as it positions itself to produce or propagate a plant or 
an animal variety is that they aren’t patentable matter. Opposing explanations of what is enclosed 
under “... any part of a plant” as under Section 3(j) of the act and the clash between the said Act and 
the Protection of Plant Varieties and Farmers' Rights Act, 2001 is best exhibited through case laws. 
The researchers have studied the following case and attempted to analyse the practical aspect of the 
research topic. 
 
3.3. The Monsanto Technology Case 
3.3.1. Facts of the Case 
Monsanto Technology LLC is an agrochemical and agricultural biotechnology corporation and was 
one of the first companies to successfully modify the genes of seeds and plants as a branch of agro-
biotech activities. Biotechnology has developed in recent years, and Monsanto puts those discoveries 
to use concerning advancing essential such as wheat, corn, cotton, soybeans, etc. Patents regarding 
genetically modified food (GMO) and biotechnology-associated plants are largely in the name of 
Monsanto. In India, Monsanto operates as a joint venture - Mahyco Monsanto Biotech Pvt. Ltd. 
(India).  
Nuziveedu Seeds is an established seed company in India, with a couple of subsidiaries. Mahyco 
Monsanto Biotech Pvt. Ltd. (India) is known to license its biotechnologically modified products to 
various seed companies in the domestic arena. In furtherance of this activity, Monsanto entered into a 
licensing agreement with Nuziveedu Seeds on 21st February 2004, the initial period of which was 10 
years, which was further prolonged by an additional year in 2014. This licensing agreement was 
related to entitling the defendants to advance and commercialise “Genetically Modified Hybrid 
Cotton Planting Seeds, granted to Monsanto India, with the help of Monsanto’s technology [7]. These 
patented seeds provided higher yield because they were resistant to boll-worm attacks. For granting 
this license, Monsanto India charged not only a lifetime fee of Rs. 50 lacs, but also periodic trait-value 
compensation. Various state governments of India, at that time, started formulating and passing novel 
guidelines for price regulation, thus the Indian companies who were given licenses by Monsanto 
requested the latter to lessen the trait-value fee. However, Monsanto rejected to do it. 
The Indian companies in question then stopped disbursing the royalties, accruing to which 
Monsanto took action on 14th November 2015. An application for the granting of an injunction was 
filed by Monsanto, claiming trademark infringement and violation of registered patent, owing to the 
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sudden and before-time termination of the licensing agreement. As a means of recovering 
compensation, Monsanto initiated arbitration proceedings. The amount they quoted from the Indian 
companies was Rs. 400 crores. 
Nuziveedu filed a counter-claim under Section 64 of the Patents Act, 1970, relying on the 
following grounds under the provision [6]: 
1. Absence of novelty 
2. Absence of obviousness 
3. Complete specification not revealing any "invention" 
4. Deficiency in complete specifications  
5. Deficiency in claim  
6. False suggestions or representations  
7. Non-compliance of the requirements of Section  
8. Non-disclosure of source or geographical origin 
9. Invention claimed in the complete specification being not useful 
 
Nuziveedu also brought forth Section 3(j) of the Act, which was serving as the imminent cause for 
withdrawal of the said patent and argued further focused on the same. The Protection of Plant 
Varieties and Farmers' Rights Act, 2001 acted as their main defence towards the protection of rights. 
 
3.3.2. Court Arguments  
3.3.2.1. Patent No. 214436 vis-a-vis Understanding of Section 3(j) of the Focus Statute 
Nuziveedu’s primary contention was that “Section 3(j) excludes certain things from the ambit of 
'inventions' [6]. Since seeds & varied species of plants and any biological method for creation or 
proliferation of plants & animals is such an exception, Nuziveedu emphasised that claim 25 of the 
Patent relates to “nucleic acid sequence [6]. The sole terms in which the sequence can be applied is "a 
plant cell, a seed, a transgenic plant or a plant variety [7]. In this case, the plant and seed having a 
nucleic acid arrangement comprising of the Cry2Ab gene could not be approved a patent in India as 
these specifications the condition of ‘industrial application’ was missing. Failing this, they fell under 
the aforesaid exclusions. Nuziveedu further said that the “BT Trait in any cotton hybrid-variety plants 
was a biological process; hence they are to be regarded as ‘natural discoveries’ made in a laboratory 
through cross-breeding [7]. 
 Monsanto India rebutted with two broad contentions – one, that the term ‘plant’ would be subject 
to interpretation as a ‘living organism’ with regards to Section 3(j) and two, that the exclusions 
mentioned in “Section 3(j) would apply only to biological beings and not creations as in this case, the 
mischief of the provision was escaped by the product in question fitting into the mould of ‘micro-
organisms’ which have been specifically mentioned as to not fall within the exceptions [6]. Monsanto 
went further to explain that it was the DNA that was responsible for any and every process in a living 
creature and a DNA segment is a code that assists in producing protein, thus not making either of 
these individually a living thing in any case. The Claim Numbers 25 to 27, which were the subject 
matter of the patent were artificial, manufactured DNA orders. These sequences possessed the CryAB 
gene, which on being incorporated into a plant’s genome, conferred plants with insect resistance. 
They stressed that no fragment of the DNA order – as is in this case, a gene - is a living creature and 
thus DNA cannot be termed as a "part" of a plant. No physical attribute of a plant and any of its parts 
or an organ of an animal is the matter of dispute herein and it is only a method of creating new and 
inventive transgenic varieties that would bring it well within the ambit of The Patents Act, 1970.  
 
3.3.2.2. Applicability of the PPV&FR Act, 2001 
The term ‘micro-organisms’ has not been defined in the “PPV&FR Act, 2001 [8]. The defendants, 
therefore, referred to the acclaimed Cambridge Dictionary and stated that a micro-organism is "A 
living thing that on its own is too small to be seen without a microscope, such as bacteria, germs, 
viruses [9]. Nuziveedu effectively negated Monsanto India’s argument regarding their patent claim. 
The TRIPS agreement which India has ratified was brought into the light, and Nuziveedu reiterated 
that it was through the push provided by TRIPS Agreement that the Plant Variety Act was enacted as 
distinct legislation from The Patents Act, 1970. The main purpose of the Act was to encourage the 
development and fortification of plant variations and safeguarding the rights of breeders. The 
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conclusion to their argument was that in the given case, seeking patent protection was an invalid 
action as the product ought to be protected by and under the provisions of the PPV&FR Act, 2001. 
 In their contentions, Monsanto India re-emphasized that the patented DNA is outside the scope of 
the term ‘plant variety’. A plant or portion/portions of the plant which could be utilised to proliferate 
the variety, a trait of a plant, chemical, or other constituents (oil, DNA, etc.), and a plant breeding 
technology are all excluded from the definition [10] A DNA segment cannot come under the term 
‘plant variety’ and it would be deprived of such registration on the justification that it does not fulfil 
the circumstances precedent in “Section 2(za) read with Sections 14 and 15 of PPV&FR Act [11].  
 Further, Monsanto elaborated on the modifications made to The Patent Act, 1970 in 2002 and 
2005. They said that when Sections 2(1) (j) and 3(j) would be read with the objects and reasons of 
these modifications, certain salient features of the Bill would be brought to light. Firstly, it would be 
the one related to modifying Section 3 of the Act and broadening its interpretation to include those 
exclusions that have been laid down by the TRIPS Agreement. To add materials like detection of any 
living or non-living things which occur in nature to the list of exceptions which in general 
circumstances do not comprise patentable invention would be the second aspect. 
 They concluded by submitting that their work was a result of innovation and skill, as they were 
inventions and products of the processes of biotechnology. Thus, the patented invention would be 
guarded under the PPV&FR Act, 2001, leaving the process to be validly patented. 
 
3.3.2.3. TM Abuse and Sub-Licensing issue 
The appellant argued that according to the facts, Nuziveedu had stopped paying trait value to 
Monsanto India even though the former was utilising the latter’s technology. The termination of the 
sub-licensing was thus perfectly legal. Monsanto were the holders of the trademarks BG I and BG II 
and had applied for an injunction to bar Nuziveedu from using the same. Finally, since the license 
agreement stood terminated and not restorable, the obligations contained therein also ceased to be 
binding upon the parties. Hence, the duty to perform the obligations under Section 14(1) of the 
Specific Relief Act, 1963 also stood negated. 
The first claim of Nuziveedu was that seeds fall under the scope of “essential commodity” [11]. 
Hence, it is only the Central Government, which is empowered to decide upon and declare the trait 
value of seeds. If such value is surpassed by a company, any licensing agreement would not be liable 
to be terminated on grounds of non-payment of the fees by the licensee to the licensor. There was also 
a rebuttal to Monsanto relying on Section 42 of the Specific Relief Act; it was asserted once again by 
Nuziveedu that it was not bound to oblige Monsanto in any way by paying the trait fees fixed by the 
latter since it was only the Central Government, which was entitled to fixate upon the same. It is thus 
conclusive that the relief under the said provision effectively negates the present case. The validity of 
terminating the licensing agreement was thus questioned, as it seemed to be an arbitrary decision 
taken by Monsanto India to harass the licensee. Nuziveedu’s penultimate submission was that since 
Monsanto India was responsible for neglecting the fact that protection for the product in question 
could only be sought under the PPV&FR Act, 2001, there was an avoidance of the provision of 
benefit sharing with the companies in the seed business who produced and marketed new BT Cotton 
plant variations expressing BT trait [12]. 
As far as the Trademark violation allegedly done by Nuziveedu was concerned, the defendants 
claimed to have made use of the abbreviations of Monsanto's trademark. The intention was to indicate 
the source which had been used for product manufacturing. Thus, the use would be classified as a 
legitimate “descriptive mark” [9]. “Moreover, infringement of a trademark can only be said to have 
occurred if a registered mark is used as 'trademark' and not in any other case [13] 
Monsanto India further rebutted these arguments. Reference was made by them to the Percy 
Schmeiser case [14]. Herein, the Court had applied the Doctrine of Purposive Construction to similar 
facts, and ultimately held that there had been “use” of the patent granted to Monsanto when an 
unauthorised person utilised the patented gene to develop and further commercialize a seed variety; 
hence there was an infringement of the aforesaid patent. Since the DNA segment was existent all over 
the seed and it gave it an advantageous trait, there was said to be a significant and noteworthy 
contribution of the patentee. A similarity was drawn to Nuziveedu’s actions in the present case, where 
the hybrid seed which had immense tolerance towards the harm generally caused by insects as a result 
of the DNA sequences which were infused in them; the sequence patented to Monsanto. Hence, there 
was a violation of patent rights when the final product was brought to the front.  
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3.3.3. Judgement and Analysis  
March 2017 saw the Hon’ble High Court at Delhi necessitating the requirement of formal proof, in the 
form of expert opinion being the top priority. The extent of domination approved by the patent claims 
could only be appropriately adjudged in these kinds of complicated matters involving patents based 
on such expert opinion. The sub-license agreement entailed certain obligations which both parties 
were instructed to remain bound by, throughout the pendency of the case proceedings. In that course, 
the laws in force at that point would have governed the license fee/trait value which was payable by 
the defendant. 
Distressed, both the parties favoured appeals. The two-judge appellate bench of the DHC upheld 
that the protection under the PPV&FR Act, 2001, and the Patent Act are mutually exclusive from each 
other and not complementary measures. It was opined by the Court that therefore, protection had to be 
sought by Monsanto India under the PPV&FR Act, 2001, according to the realities and situations of 
the case. Further, the court observed that Section 10(4) of the Patents Act had not been complied with 
by the respondents as they had not disclosed the required details regarding the source of the said 
‘invention.’ 
The Court ultimately held that the subject matter falls inside the exclusions stated in Section 3(j) of 
the Patents Act, which essentially makes the product non-patentable. The Court declared that the 
respondents ought to claim restoration of their right in the disputed patent and the patented invention, 
given they applied and obtained registration over the subject matter under the proper and appropriate 
law within a time-limit of three months from the date of order i.e. 11th July 2018. Insofar as the 
infringement of a trademark by appellants was concerned, the same was excused as covered within 
the ambit of Section 2(o) of The Trademarks Act. The respondent, as mentioned earlier, had claimed 
damages worth Rs. 400 crores from the licensees, which was held to be wrong, by the court. 
The facts and technical methods involved in the patent were immense and intense and were heard 
by the Hon’ble Supreme Court of India in as much detail, with as much attention as was deemed 
appropriate. However, it desisted voicing any opinion on any of those issues when it gave a 
judgement on January 8, 2019, in the present case. It noted that very elaborate submissions had been 
made in front of it, given that the facts were exceedingly technical and so were the processes involved 
throughout, which gave rise to the dispute. However, on this front, the Court concluded that because 
of the nature of the order that is sought to be passed, all the above information stood irrelevant at that 
stage. All questions of law and fact, the Court said, ought to be considered in suitable proceedings.  
An important point to be noticed was that the defendants had made a counter-claim at the early 
stage which was not considered by the Delhi High Court. The plaintiffs had favoured an appeal 
against the injunction order against them regarding the issuing of license fees. The Division Bench to 
which the appeal had been preferred ought to have restricted itself to adjudge only if the grant of the 
injunction by the single judge bench was correct or incorrect, given the actualities and conditions of 
the case. It was an error on the part of the Division Bench to have scrutinized the counter-claim itself, 
which was a borderline infringement of the dominion of the single-Judge Bench to decide non-
patentability of the process claim 124, that too in the summary manner it was done. This was not a 
permissible move in the eyes of law, let alone being desirable. Evidence was required to be examined 
to answer the exceedingly complicated questions of fact and law involved in the case, mainly 
associated with the patentability of things and exclusion of such rights in certain cases. 
The Court took into account the provisions of “Section 64 of The Patents Act, 1970” and Section 
9, Order 12 Rule 6 and Order 16 of “Rule 1 of the Civil Procedure Code, 1908” and was satisfied that 
the Division Bench made a grave error in disposing of the suit. The Court pointed out that only 
documents extracted from the public domain which had not even been filed as exhibits in the suit had 
been relied upon by the Division Bench to make the decision. The observation in the case of Alka 
Gupta vs. Narender Kumar Gupta was taken into account wherein it was noted that “a civil 
proceeding governed by the Code will have to be proceeded with and decided according to the law” 
[15] . That, alongside the provisions of the Code, would be the deciding factor as opposed to the 
whims of any court. Unless given under the law, there should be no short-cuts in the trail of 
litigations. A step-by-step process in a case cannot be cut down upon by determining issues of fact 
simply on pleadings and documents produced without a trial. In light of all the notations so made, the 
order of the Division Bench was set aside. The Supreme Court upheld the initial order of the Delhi 
High Court and redirected the case to the same for disposal in accordance with appropriate laws. The 
appeals and the intervention applications were disposed of. 
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It is quite clear that the Supreme Court of India is intent upon having a case-to-case approach as 
far as issues related to patenting GM plants is concerned since there are a lot of technicalities and 
special knowledge involved. The position of patent fortification for “Genetically Modified Plants” is 
currently ambiguous in India and is a flaming dispute, the arguments for and against which have to be 
framed with monetary and moral considerations. The requirement for reliable public policy and 
vigorous frameworks for supervisory control is especially important considering India’s desire to 
adopt and step towards an innovation-based economy. That also gives birth to vital challenges to the 
whole idea of introducing India to genetically engineered or modified crop plants.  
 
3.4. Farmer’s Rights Act, 2001 And Plant Varieties 
The Government of India formulated the abovementioned act according to the standards laid down by 
TRIPS, regarding setting up a “sui generis” system. The Act has also been made in consonance with 
the International Union for the Protection of New Varieties of Plants (UPOV), 1978, and the standards 
laid down therein. The main objective behind the formulation of the legislation was to guard the rights 
of the breeders and also to provide an incentive for the invention of novel plant variations. 
To implement this legislation, the Protection of Plant Varieties and Farmers' Rights Authority was 
established on 11th November 2005. There are a total of 15 members appointed by the Government of 
India and apart from that; the Chairperson is the Chief Executive Authority. “A variety is eligible for 
registration under the Act if it essentially fulfils the criteria of Distinctiveness, Uniformity, and 
Stability (DUS) [16].After the registration is completed, a certificate of registration shall be provided 
which shall be valid for a period of nine years in case of trees & vines and a period of six years in case 
of crops. The registration can also be renewed on the payment of the requisite fees but in no 
circumstance shall it go beyond a period of eighteen years in case of trees & vines and fifteen years in 
case of crops. The issues arising out of this particular statute shall be looked into by the “PVPAT” 
[17]. An appeal can be filed against the decision given by the PVPAT to the High Court. 
 
4. Conclusion 
To build-up an innovation-based economy, it is very much necessary to clarify the scope of protection 
of the technological processes required for developing the genetically modified crops and trees. 
However, in the case analysis, we saw that the Apex Court has not yet given any interpretation of 
section 3(j) of the Patent’s Act, 1970. It has dismissed the case on the ground that it did not follow the 
proper procedures of law i.e. expert evidence was not taken, which was an essential part of this 
proceeding as the matter involved chemical and biotechnological issues. The matter has been returned 
to the Delhi High Court. Therefore, a clarification of the judiciary on the required provisions of the 
Act is the need of the hour to understand the scope and extent to which the Act can be applied and 
move ahead with the inventions accordingly. 
Though an interpretation of the above section is yet to be provided by the Apex Court, referring 
back to the TRIPS agreement and the submissions made by the Legislature afore the 2002 
modifications of the Patent law, it seems to be quite evident that patentability of plants, plant varieties, 
and even seeds was kept excluded from the jurisdiction of the Patent Act and they were left to be 
governed by the Farmer’s Rights Act, 2001. TRIPS had provided an open option to the countries to 
give protection to plant varieties either under patents or a sui generis system or a combination of both. 
A statutory review was scheduled by the signatory states whereby each of them represented their 
views on the given article. India had also provided its views against the same. After going through the 
submissions made by the various ministries, it was prominent that only “Genetically Modified 
Organisms” can be protected under the existing domestic law. However, plant varieties were seen to 
be excluded from the purview of patentability. The same was prescribed to be governed by the Plant 
Varieties and Farmers Rights Legislation. These submissions and reports were the foundation on 
which the modification was based on, excluding plant varieties. Therefore, from the entire study made 
above, it can be concluded by stating that the legal framework on the rights of the breeders, biotech 
companies and farmers have been made in a balanced way so that none of their rights gets violated. 
India has protected the rights in such a manner that any of them doesn’t get violated. Among the 
options provided under the TRIPS agreement, India has chosen to provide a combination of patents 
and sui generis system to protect genetically modified organism and only sui generis system has been 
used to provide protection to plant varieties. 
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